1. Home
  2. INCY vs PNFP Comparison

INCY vs PNFP Comparison

Compare INCY & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incyte Corp.

INCY

Incyte Corp.

HOLD

Current Price

$117.62

Market Cap

17.0B

Sector

Health Care

ML Signal

HOLD

Logo Pinnacle Financial Partners Inc.

PNFP

Pinnacle Financial Partners Inc.

HOLD

Current Price

$102.19

Market Cap

14.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
INCY
PNFP
Founded
1991
2000
Country
United States
United States
Employees
N/A
3709
Industry
Biotechnology: Commercial Physical & Biological Resarch
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
17.0B
14.9B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
INCY
PNFP
Price
$117.62
$102.19
Analyst Decision
Buy
Buy
Analyst Count
21
17
Target Price
$103.52
$113.31
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
04-28-2026
04-22-2026
Dividend Yield
N/A
2.05%
EPS Growth
4173.33
N/A
EPS
1.47
N/A
Revenue
$3,394,635,000.00
N/A
Revenue This Year
$10.44
$160.52
Revenue Next Year
$10.99
$9.24
P/E Ratio
$79.38
$12.24
Revenue Growth
13.67
N/A
52 Week Low
$69.70
$81.08
52 Week High
$119.60
$107.00

Technical Indicators

Market Signals
Indicator
INCY
PNFP
Relative Strength Index (RSI) 62.08 56.89
Support Level $98.50 $92.68
Resistance Level $119.29 $107.00
Average True Range (ATR) 3.08 2.68
MACD -0.45 -0.21
Stochastic Oscillator 80.75 77.24

Price Performance

Historical Comparison
INCY
PNFP

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

Share on Social Networks: